Consensus 10x Genomics, Inc.

Equities

TXG

US88025U1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
27.58 ^USD	-0.79%		-10.45%	-50.71%

Apr. 18	Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating	MT
Mar. 26	10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay	CI

Evolution of the average Target Price on 10x Genomics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2082192c1e3a4ebb0f.EXYCC1V2z3XrBfKuXLkNrnGPoH7rqwGPjwZ5oD-Q4ME.ZDljUxpbiyKZTd-bKvJl-BSilDqx_FDi0Hw9xlTJqLlOH1dOGhiiEoxpuw~5e622a048cfd88f07669f39d239cd5b2

Analyst Recommendations on 10x Genomics, Inc.

Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating	Apr. 18	MT
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating	Feb. 21	MT
Stifel Cuts Price Target on 10x Genomics to $63 From $68, Maintains Buy Rating	Feb. 16	MT
Barclays Adjusts Price Target on 10x Genomics to $55 From $45, Maintains Overweight Rating	Jan. 25	MT
Wolfe Research Initiates 10x Genomics With Outperform Rating With $55 Price Target	Dec. 13	MT
BofA Securities Upgrades 10x Genomics to Neutral From Underperform, Adjusts Price Target to $54 From $36	Dec. 12	MT
UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating	Nov. 07	MT
Barclays Lowers Price Target on 10x Genomics to $47 From $66, Maintains Overweight Rating	23-09-29	MT
Citigroup Adjusts Price Target on 10x Genomics to $75 From $65, Maintains Buy Rating	23-08-04	MT
UBS Adjusts Price Target on 10x Genomics to $62 From $58, Maintains Neutral Rating	23-08-04	MT
Deutsche Bank Adjusts 10x Genomics Price Target to $65 From $56, Maintains Buy Rating	23-08-02	MT
Goldman Sachs Adjusts Price Target on 10x Genomics to $30 From $25, Maintains Sell Rating	23-07-13	MT
Barclays Initiates 10x Genomics at Overweight With $65 Price Target	23-05-10	MT
Stifel Nicolaus Adjusts 10x Genomics Price Target to $68 From $57, Maintains Buy Rating	23-05-04	MT
TD Cowen Adjusts Price Target on 10x Genomics to $66 From $62, Maintains Outperform Rating	23-05-04	MT
UBS Adjusts 10x Genomics Price Target to $58 From $54, Maintains Neutral Rating	23-05-04	MT
UBS Raises Price Target on 10x Genomics to $54 From $50, Keeps Neutral Rating	23-04-10	MT
Stephens Starts 10x Genomics at Overweight With $65 Price Target	23-03-31	MT
Morgan Stanley Raises 10x Genomics' Price Target to $65 From $64, Maintains Overweight Rating	23-02-16	MT
Deutsche Bank Adjusts 10x Genomics Price Target to $56 From $50, Maintains Buy Rating	23-02-16	MT
UBS Initiates Coverage on 10x Genomics With Neutral Rating, $50 Price Target	23-02-02	MT
Deutsche Bank Initiates Coverage on 10x Genomics With Buy Rating, $50 Price Target	22-12-14	MT
Morgan Stanley Adjusts Price Target on 10x Genomics to $64 From $70, Maintains Overweight Rating	22-11-04	MT
Goldman Sachs Lowers Price Target on 10x Genomics to $25 From $35, Maintains Sell Rating	22-10-13	MT
Goldman Sachs Downgrades 10x Genomics to Sell From Neutral, Lowers Price Target to $35 From $55	22-08-18	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.58 USD

Average target price

52.29 USD

Spread / Average Target

+89.58%

High Price Target

65 USD

Spread / Highest target

+135.68%

Low Price Target

30 USD

Spread / Lowest Target

+8.77%

Consensus detail

Consensus revision (last 18 months)

Analysts covering 10x Genomics, Inc.

Deutsche Bank Securities
UBS
Stifel Nicolaus
Barclays
Wolfe Research
BofA Securities
Citigroup
Goldman Sachs
TD Cowen
Stephens Inc.
Morgan Stanley
JPMorgan Chase
Canaccord Genuity
William Blair & Co.
Cowen
J.P. Morgan Chase

Ratings for 10x Genomics, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar